Synthesis and biological activity of dehydrophos derivatives

被引：0
作者：
Jiménez-Andreu M.M. [1 ]
Lucía Quintana A. [2 ,3 ]
Aínsa J.A. [2 ,3 ]
Sayago F.J. [1 ]
Cativiela C. [1 ]
机构：
[1] Departamento de Química Orgánica, Instituto de Síntesis Química y Catálisis Homogénea ISQCH, CSIC-Universidad de Zaragoza, Zaragoza
[2] Departamento de Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, BIFI, Universidad de Zaragoza, Zaragoza
[3] CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid
来源：
Organic and Biomolecular Chemistry | 2019年 / 17卷 / 05期
关键词：
D O I：
10.1039/c8ob03079k
中图分类号：
学科分类号：
摘要：
The synthesis of dehydrophos derivatives featuring modified peptide chains, characterized by the presence of substituents in the vinyl moiety, or possessing a phosphonic acid monoalkyl ester other than the monomethyl ester one, has been accomplished by a versatile procedure based on Horner-Wadsworth-Emmons olefination with suitable aldehydes and on the selective hydrolysis of the dialkyl phosphonate group. Such derivatives have been tested against a series of bacterial strains, using the naturally occurring peptide, dehydrophos, for comparison. Thus, the effects of the aforementioned structural variations on antimicrobial activity have been studied. ©2019 The Royal Society of Chemistry.
引用
收藏
页码：1097 / 1112
页数：15
相关论文
共 54 条
  • [21] Atherton F.R., Hall M.J., Hassall C.H., Lambert R.W., Lloyd W.J., Lord A.V., Ringrose P.S., Westmacott D., Antimicrob. Agents Chemother., 24, pp. 522-528, (1983)
  • [22] Atherton F.R., Hall M.J., Hassall C.H., Lambert R.W., Lloyd W.J., Ringrose P.S., Westmacott D., Antimicrob. Agents Chemother., 22, pp. 571-578, (1982)
  • [23] Atherton F.R., Hall M.J., Hassall C.H., Lambert R.W., Ringrose P.S., Antimicrob. Agents Chemother., 15, pp. 677-683, (1979)
  • [24] Atherton F.R., Hassall C.H., Lambert R.W., J. Med. Chem., 29, pp. 29-40, (1986)
  • [25] Lejczak B., Kafarski P., Sztajer H., Mastalerz P., J. Med. Chem., 29, pp. 2212-2217, (1986)
  • [26] Laber B., Lindell S.D., Pohlenz H.-D., Arch. Microbiol., 161, pp. 400-403, (1994)
  • [27] Kugler M., Loeffler W., Rapp C., Kern A., Jung G., Arch. Microbiol., 153, pp. 276-281, (1990)
  • [28] Diddens H., Zahner H., Kraas E., Gohring W., Jung G., Eur. J. Biochem., 66, pp. 11-23, (1976)
  • [29] Circello B.T., Miller C.G., Lee J.H., Van Der Donk W.A., Metcalf W.W., Antimicrob. Agents Chemother., 55, pp. 3357-3362, (2011)
  • [30] Sanders S., Vierling R.J., Bartee D., Decolli A.A., Harrison M.J., Aklinski J.L., Koppisch A.T., Freel Meyers C.L., ACS Infect. Dis., 3, pp. 467-478, (2017)
123456